Purchase Order 11316025P0005OND
Award Date
9/18/25
Potential Completion Date
9/17/26
Potential Value
$616K
Federal Agency
Office of Administration
Awardee
Biobot Analytics Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $799,971 firm fixed price purchase order to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide wastewater-based monitoring of illicit drugs from September 1, 2023 through August 31, 2024. This contract is not set aside. Biobot Analytics is a company that specializes in wastewater epidemiology data and analysis, and has previously...
This firm fixed price purchase order from the Department of Health and Human Services (HHS) awards Biobot Analytics Inc. $1.94 million to provide COVID-19 wastewater data testing services. The contract supports HHS' Office of the Assistant Secretary for Administration under the Coronavirus COVID-19 national interest code. Per the solicitation, Biobot will collect and test samples from at least 320 wastewater treatment facilities serving over 100 million U.S. citizens across all 50 states and...
This is a firm fixed price purchase order (contract) awarded by the Defense Health Agency to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide SARS-COV-2 analytical services. The contract is valued at $129,600.00 and has a completion date of March 13, 2025. The original solicitation was set aside for total small business and required the contractor to provide ribonucleic acid (RNA) virus detection using quantitative polymerase chain reaction (qPCR) and reverse...
This is a $3,120.00 firm fixed price purchase order contract awarded to Biobot Analytics Inc., a self-certified small disadvantaged business, by the Medical Command (MEDCOM) component of the U.S. Department of Defense. The contract is for COVID-19 wastewater sample analysis services, with a performance period ending on June 1, 2022. Biobot Analytics has prior experience providing wastewater-based monitoring services to government agencies, including contracts with the National Institutes of...
The U.S. Army Public Health Center in Aberdeen, Maryland awarded a $81,120 firm fixed price purchase order to Biobot Analytics Inc. for COVID-19 wastewater sample analysis. The contract was not set aside. Biobot Analytics is a small disadvantaged business that specializes in wastewater epidemiology data and analysis. This award is part of the Defense Health Agency's efforts to monitor COVID-19 through wastewater testing. Biobot Analytics has prior experience providing wastewater-based monitoring...
The Centers for Disease Control and Prevention awarded a $31 million firm fixed price contract to Biobot Analytics Inc. to provide commercial wastewater surveillance testing services in support of the National Wastewater Surveillance System. Under the terms of the contract, Biobot Analytics will quantitatively test wastewater samples twice weekly for SARS-CoV-2 and sequence qualifying samples over an 11-month period from April 2022 through February 2023. The contract is set aside for small...
This $23,040 firm-fixed-price purchase order was awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biobot Analytics Inc., a self-certified small disadvantaged business. The contract is for Biobot to provide monthly COVID-19 wastewater sampling, testing, and data analysis services for the Fort Belknap Reservation in Montana. The period of performance is from September 1, 2020 through August 31, 2021. This award was made through...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $681,553.26 firm fixed-price definitive contract to Aquavitas, LLC, a for-profit limited liability company, for genomic sequencing of wastewater samples and analysis to detect the presence of the SARS-CoV-2 virus. The contract, which does not have a set-aside designation, has a completion date of February 14, 2022 and was awarded on September 24, 2021. The place of performance is Scottsdale, Arizona....
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a purchase order contract to Soller Environmental, LLC, a small consulting firm, for wastewater surveillance services. The $134,985 time and materials contract supports COVID-19 monitoring efforts through wastewater surveillance modeling. As a subcontractor, Soller Environmental has also provided toxicological and microbial support services to the Environmental Protection Agency's Health and Ecological...
The Centers for Disease Control and Prevention (CDC) has awarded a $38,760,799.92 firm-fixed-price definitive contract to Verily Life Sciences LLC, a subsidiary of Alphabet Inc., to provide wastewater surveillance testing services. The contract, which has no set-aside designation, will support the CDC's ongoing COVID-19 and monkeypox response efforts, as well as prepare for future public health emergencies. Under the contract, Verily will establish sample collection relationships with wastewater...